EVO756 (MRGPRX2 antagonist) Chronic Inducible Urticaria Clinical Trial
Do you have Urticaria also known as Hives?
OptiSkin is looking for healthy volunteers to join our paid clinical trials. Eligible volunteers with urticaria will receive free biologic medication. Volunteer today and help pave the next generation of urticaria treatments.
Duration
Study length is 8-10 weeks after enrollment. There are a total of 4 in-person visits required. Participants will be compensated for time and travel.
Study Specifics
For adult patients 18+ who have been diagnosed with urticaria. Patients must be treated with EVO756 (MRGPRX2 antagonist) therapy once enrolled.
Eligibility
To participate, you MUST have:
- Urticaria also known as Hives brought on by pressure
You will NOT be eligible if:
- you have received Otezla® (apremilast) in the past
- your child is currently enrolled in another clinical trial
Additional inclusion/exclusion criteria will apply.